Nasopharyngeal culture, direct immunofluorescence, and serology of acute-phase and paired serum specimens were compared for the laboratory diagnosis of infections due to Bordetella pertussis in a community-based pediatric population with both high vaccine usage and high pertussis incidence. In 77 (37%) of 210 patients evaluated, one or more tests were positive for pertussis. A clinical illness compatible with pertussis was present in 52 (71%) of 73 pertussis test-positive and 42 (35%) of 119 test-negative patients (P < 0.001). Nasopharyngeal culture was of low sensitivity (20 [26%] of 77 positive tests) but was most commonly confirmed by another positive pertussis test (85%). Direct immunofluorescence was both insensitive and nonspecific; only 6 (30%) of 20 cases positive by culture were positive by immunofluorescence, and only 4 (33%) of 12 of the culture-negative, immunofluorescence-positive cases could be confirmed by another positive pertussis test. Although serology by enzyme immunoassay proved to be the most sensitive of the laboratory tests (87%), this sensitivity could be achieved only by assaying both acute-phase and paired serum specimens and measuring immunoglobulin G (IgG), IgA, and IgM antibodies to two pertussis antigens (pertussis toxin and filamentous hemagglutinin). Loss of sensitivity occurred with any reduction in the number of these serologic assays performed. Optimal laboratory diagnosis of endemic pertussis in a pediatric population requires both nasopharyngeal culture and serology by enzyme immunoassay.
The unavailability of sensitive laboratory tests for the diagnosis of pertussis hampers investigators who attempt to evaluate the epidemiology of the disease or the efficacy of the vaccine in preventing illness. Techniques routinely available in clinical laboratories include culture and direct immunofluorescence on nasopharyngeal secretions (2, 30) ; however, both tests lack sensitivity, and the latter also lacks specificity (3, 31) . Some investigators have recently suggested that serologic methods may increase the diagnostic sensitivity. Such tests have usually measured specific antibody to the whole organism, Bordetella pertussis, in nasopharyngeal secretions (10) or in serum (21, 27, 39) . More recently, these assays have been modified to detect antibodies to purported B. pertussis virulence factors (filamentous hemagglutinin [FHA] and pertussis toxin [PT] ) in serum (1, 13, 15, 38) and in secretions (11) . Unfortunately, the lack of standardized methods has prevented these tests from becoming universally available.
Difficulties in a prompt laboratory diagnosis of pertussis derive from the nature of the pathophysiology of the infection caused by B. pertussis. Typical signs and symptoms of pertussis do not occur until week 3 of infection, during the paroxysmal phase of illness (33) . However, isolation of B. pertussis is most consistent in the catarrhal or early paroxysmal stage, often before the diagnosis of pertussis is suspected (24) . In addition, infants, older children, adults, and previously immunized individuals may never develop the classical clinical manifestations of whooping cough. Although diagnostic methods relying on paired serum specimens (PS) may be more sensitive, they do not permit confirmation of infection during the acute phase, since proper timing of the follow-up serum is critical (31) . Serologic methods using a single acute-phase serum specimen (AS) have also been proposed; these rely on combinations of * Corresponding author.
titers of various antibody classes to differentiate antibody due to acute infection from antibody due to prior immunization (39) .
Improved laboratory methods to aid in the diagnosis of pertussis are crucial in obtaining accurate epidemiologic data on pertussis incidence and vaccine efficacy. Recent studies have evaluated pertussis diagnostic tests which use crude bacterial antigen preparations (21) , for diagnosis in unimmunized populations (39) , or for diagnosis in adults during an outbreak (38) . Although the results of these studies are generally favorable toward the tests, it is not clear whether these methods would be suitable for laboratory diagnosis of pertussis in an immunized population or during nonoutbreak situations. In this study we assessed a number of assays, including nasopharyngeal culture, direct immunofluorescence, and antibody to PT and FHA in AS and PS, in order to determine their suitability as diagnostic tests. The study was done in a community-based pediatric population with both high vaccine usage and high pertussis incidence.
MATERIALS AND METHODS
Population, specimen collection, and processing. The Izaak Walton Killam Hospital for Children (IWK) is the only pediatric hospital and diagnostic center for the city of Halifax (population, 250,000) and serves as a referral center for the maritime provinces of Canada (population, 1,500,000). The incidence of reported pertussis is approximately 13 cases per 100,000 people. Patients in whom pertussis was suspected were evaluated by nasopharyngeal culture and smear and by serology. At the time of presentation, secretions were collected by syringe aspiration through a fine flexible plastic catheter passed through the nose into the nasopharynx as previously described (10) . In addition, a blood sample was obtained by finger stick, and a questionnaire detailing symptomatology, immunization status, and recent use of antimicrobial agents was completed.
EVALUATION OF METHODS FOR THE DIAGNOSIS OF PERTUSSIS
Arrangements were made for collection of a 3-week follow-up serum specimen; patients were reminded by telephone prior to their appointment. Nasopharyngeal secretions were immediately transported in the catheter from the Outpatient Diagnostic Centre to the microbiology laboratory of the IWK. There, nasopharyngeal secretions were expelled onto agar plates for culture and onto two clean glass slides for immunofluorescence. Smears were processed by treatment with aprotinin (4 U/ml) (18) and were stored at 4°C until examination. Serum was separated and stored at -20°C. Most specimens were completely processed within 1 h of collection, thereby eliminating the need for transport media; the few specimens collected overnight were so-called "gold standard") against which other tests can be assessed. The use of multiple diagnostic tests in combination may result in improved sensitivity, but often with a concurrent loss of specificity (14) . Additionally, evaluation of diagnostic tests in an outbreak situation can mask tests of low specificity, since the true positive rate is so uncommonly high. In this study we assessed this issue by using a combination of tests as potential "gold standards," and these were then compared with single or multiple combinations of tests. The study was performed during a 14-month period of moderate endemic pertussis activity rather than during an outbreak. During this period, 20 culture-confirmed cases occurred; by contrast, 88 culture-confirmed cases had occurred during an epidemic year encompassed in the preceding 14-month period (unpublished data). Nasopharyngeal culture proved to be a test of low sensitivity but high specificity, while direct immunofluorescence lacked both sensitivity and specificity. These results of our assessment of methods for detecting bacteria in nasopharyngeal secretions are similar to those in previous reports. By a variety of criteria, culture sensitivity has been estimated to be 30 to 60% (6, 12, 13, 15, 27, 28, 38, 39 
